Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NCORAL D3 is a combination nutritional supplement developed and marketed by Neurogenics Therapeutics, primarily indicated for the management of calcium deficiency and the maintenance of bone health. It contains coral calcium, a natural source of calcium carbonate derived from coral reefs, and cholecalciferol (Vitamin D3). Cholecalciferol acts as an agonist at the Vitamin D receptor (VDR), promoting the intestinal absorption of calcium and phosphate, which are critical for bone mineralization. Coral calcium provides the necessary calcium ions required for skeletal integrity and various physiological processes, including muscle contraction and nerve signaling. This combination is commonly used in the treatment and prevention of osteoporosis, osteomalacia, and hypocalcemia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on coral calcium + cholecalciferol.